STRAUMANN USA, LLC
ANDOVER, MA

Based in Andover, Massachusetts, Straumann USA LLC serves as a dedicated subsidiary of the renowned Straumann Group, focused on advancing implant dentistry and oral tissue regeneration. Since its incorporation on March 24, 2017, it's been committed to pushing the boundaries through research and evidence-based solutions for dental professionals worldwide. The organization excels in offering a comprehensive range of products that include implants, state-of-the-art instruments, prosthetics, and high-quality biomaterials to support tooth replacement and restorative procedures. Straumann USA bridges traditional treatment methods with cutting-edge digital workflows such as guided surgery, intra-oral scans, and CAD/CAM restorations, keeping pace with the dynamic needs of dental practices. As part of a global dental powerhouse known for its innovation, quality, and excellence, Straumann USA works alongside international brands such as Instradent, Neodent, Medentika, and etkon. It maintains strategic alliances with leading clinics, research institutes, and universities to bolster its R&D initiatives, reinforcing the collective vision of exceptional oral health solutions. Production facilities are strategically located in Switzerland, Europe, the United States, and Japan, enabling Straumann USA to uphold stringent quality standards across its global distribution network that spans over 100 countries. The company's drive for innovation is complemented by its commitment to entrepreneurship and sustainability, creating valuable opportunities not only for stakeholders but also in championing a work culture attractive to top industry talent. An important aspect of Straumann USA's approach is the ethical management of product samples offered to patients gratis, ensuring transparency as per professional guidelines around the valuation of promotional items. The team’s leadership comprises dedicated figures like Andreas Meier, Aurelio Sahagum, and Yang Xu, who ensure smooth operations and adherence to regulatory standards. This dedication was evident with key filings, notably a February 12, 2018 update on registered agents and an annual report filed in early February 2024.